prevalence of viral Hepatitis on End Stage kidney Disease patients on Dialysis in Tarhana

Authors

  • Munay Alzarqani Ali Microbiology, Department of Life Sciences, Faculty of Science, Azzaytuna University Tarhuna, Libya
  • Mufeedah Abdulali Abdullh Department of Life Sciences, Faculty of Science, Azzaytuna University, Tarhuna, Libya.

Keywords:

Viral hepatitis, End-stage kidney disease, Hemodialysis, Hepatitis B virus, Hepatitis C virus

Abstract

This study aimed to determine the prevalence of viral hepatitis among patients with end-stage kidney disease undergoing hemodialysis in Tarhuna. A descriptive cross-sectional design was used, including a total sample of 140 patients. The results showed that the prevalence of hepatitis B virus infection was 6.4%, while hepatitis C virus infection was detected in 3.6% of patients. HIV infection was very low, Most patients received three hemodialysis sessions per week, and hypertension was the most common associated chronic condition. The study highlights the importance of regular screening, hepatitis B vaccination, and strict adherence to infection-control measures in dialysis units to reduce viral transmission and improve patient safety.

References

Ahmed, R. H., Al-Nagar, N., Al-Subol, I., Al-Wahbi, R., Al-Sabahi, M., Al-Sabahi, M., Al-Sabahi, K., Shomasi, A., & Al-Hamodi, A. (2024). The prevalence and associated factors of hepatitis B and C virus in hemodialysis patients in Ibb Governorate, Yemen. Cureus, 16(9), e70112. https://doi.org/10.7759/cureus.70112

Alkhalifah, R. H., Alhaddad, M. J., Alhashem, A. T., Alwesaibi, H., AlKhalaf, A. A., Saad, A. A., Almattar, M., Alkhalaf, M. A., Alramadhan, H., & Albaggal, M. (2023). Prevalence of hepatitis B virus, hepatitis C virus, and HIV infections in hemodialysis patients at Kano Kidney Center. Cureus, 15(7), e41769. https://doi.org/10.7759/cureus.41769

Amber, A. A., Al-Kaseer, E., & Al-Diwan, J. K. (2021). Hepatitis C virus infection among patients in hemodialysis unit at Baghdad Teaching Hospital. Iraqi Medical Journal, 67(2), 51–56.

Awan, A. A., Jadoul, M., & Martin, P. (2020). Hepatitis C in chronic kidney disease: An overview of the KDIGO guideline. Clinical Gastroenterology and Hepatology, 18(10), 2158–2167.

Borges do Nascimento, I. J., Pac, A., Zanghelini, F., Civile, V. T., Correa, N. E., & Abdulazeem, H. M. (2023). Hepatitis B immunisation for adults with end-stage kidney disease (Protocol). Cochrane Database of Systematic Reviews, 2023(5), CD014764. https://doi.org/10.1002/14651858.CD014764

Ghazzawi, I., Yassin, M., Alshebly, H., Sheyyab, S., Alqudah, B., & Alwahadni, N. (2015). Prevalence of hepatitis B and C viruses in hemodialysis patients at JRMS. Journal of the Royal Medical Services, 22(2), 69–75. https://doi.org/10.12816/0011376

Kumar, R., Saravanan, M., & Nandhakumar, M. (2025). Prevalence of hepatitis B and C infection in predialysis and dialysis chronic kidney disease in a tertiary care centre. International Journal of Academic Medicine and Pharmacy, 7(6), 197–202. https://doi.org/10.47009/jamp.2025.7.6.38

Uğur, A. R., Ezer, B., Feyzioğlu, B., & Özdemir, M. (2025). Investigation of the prevalence of HBV, HCV and HIV in patients receiving hemodialysis treatment for chronic renal failure. Viral Hepatitis Journal, 31(2), 36–40. https://doi.org/10.4274/vhd.galenos.2025.2024-11-1

Martin, P., Awan, A. A., Berenguer, M. C., Bruchfeld, A., Fabrizi, F., Goldberg, D. S., Jia, J., Kamar, N., Mohamed, R., Pessoa, M. G., Pol, S., Sise, M. E., Balk, E. M., Gordon, C. E., Adam, G., Cheung, M., Earley, A., & Jadoul, M. (2022). Executive summary of the KDIGO 2022 clinical practice guideline for the prevention, diagnosis, evaluation, and treatment of hepatitis C in chronic kidney disease. Kidney International, 102(6), 1228–1237. https://doi.org/10.1016/j.kint.2022.07.012

KDIGO. (2022). KDIGO 2022 clinical practice guideline for the prevention, diagnosis, evaluation, and treatment of hepatitis C in chronic kidney disease. Kidney International, 102(Suppl 6S), S129–S205.

KDIGO. (2018). KDIGO 2018 clinical practice guideline for the prevention, diagnosis, evaluation, and treatment of hepatitis C in chronic kidney disease. Kidney International Supplements, 8(3), 91–165.

Alshebani, T. B., Alruwaili, Y. M., Alruwaili, M. H., Alotaibi, A. N., Alshaybah, F. A., Alomran, A. Y., Al-Shaban, W. R., Alsaadi, N. R., Alhawsawi, M. A., Alanazi, D. F., & Alhassan, S. H. (2023). Prevalence of hepatitis B and hepatitis C virus in haemodialysis patients. International Journal of Community Medicine and Public Health, 10(1), 342–345.

Dubey, T. N., Sharma, J., & Rathore, B. (2016). Prevalence of hepatitis B and C viruses in hemodialysis patients in central India. Global Journal for Research Analysis, 5(5), 119–121.

رعد مجيد، مريم. (2019). التهاب الكبد الفيروسي (B). بحث بكالوريوس، كلية العلوم، جامعة القادسية، العراق.

Ibrahim Mouftah Ali Altourshani, Giuma M Saleh Abubker, Abdul Rahman Mohammed Aqarib, Huda Almadani Misbah, Kholoud Emhimmid Ali, & Malak Shaban Rmadan. (2025). A retrospective Study of Comorbidity-Associated Anaemia in Hemodialysis Patients at Tarhuna Teaching Hospital. Journal of Libyan Academy Bani Walid, 1(2), 284–298. https://doi.org/10.61952/jlabw.v1i2.343

Malak Emran Dakeal, Awatif Ahmed Eshtiwe, & Ali Alamari Almakhrem. (2025). Analysis of Biochemical Profiles in Healthy Individuals, Chronic Kidney Disease, and Diabetic Kidney Disease Patients Undergoing Hemodialysis: A Cross-Sectional Study in Tarhuna, Libya. Journal of Libyan Academy Bani Walid, 1(4), 293–300. https://doi.org/10.61952/jlabw.v1i4.391

Najib Mohamed Eljabu, Tahani Meftah Zaggout, & Hajer Ali Ben Naser. (2026). Thyroid Hormone Levels among Patients with Chronic Kidney Disease and Hemodialysis-Dependent Renal Failure at Misrata Dialysis and Kidney Treatment Center: A Cro ss-Sectional Study. Journal of Libyan Academy Bani Walid, 2(3), 01–09. Retrieved from https://journals.labjournal.ly/index.php/Jlabw/article/view/560

Mustafa khalifa Ali. (2025). Prevalence of ABO blood grouping among chronic kidney disease patients on hemodialysis in Tripoli. Libya. Journal of Libyan Academy Bani Walid, 1(4), 72–78. https://doi.org/10.61952/jlabw.v1i4.270

Hanan Abu Almajd Mohammed. (2026). Impact of Climatic Factors on Hepatitis A Virus Transmission in Benghazi, Libya. Journal of Libyan Academy Bani Walid, 2(1), 172–181. https://doi.org/10.61952/jlabw.v2i1.432

Jamila Ali Ahmed Zaed. (2026). Prevalence of Kidney Failure and Its Relationship with Diabetes Mellitus: A Field Study of Dialysis Patients in Selected Centers in Western Libya. Journal of Libyan Academy Bani Walid, 2(2), 01–21. https://doi.org/10.61952/jlabw.v2i2.463

Downloads

Published

2026-05-15

How to Cite

Munay Alzarqani Ali, & Mufeedah Abdulali Abdullh. (2026). prevalence of viral Hepatitis on End Stage kidney Disease patients on Dialysis in Tarhana. Journal of Libyan Academy Bani Walid, 2(3), 79–98. Retrieved from https://journals.labjournal.ly/index.php/Jlabw/article/view/587

Issue

Section

Applied Sciences